Description
Copper bis-3,5-diisopropylsalicylate exhibits anti-diabetic, analgesic, antioxidative, immunomodulatory, anti-fibrotic, and anticancer chemotherapeutic activities. Copper bis-3,5-diisopropylsalicylate decreases hyperglycemia and DNA damage in diabetic rats and also exhibits radical scavenging and electron accepting abilities in other models. This compound increases levels of bronchoalveolar cells and neutrophils, decreases levels of macrophages and lymphocytes, and suppresses the development of lung fibrosis in animal models. Additionally, copper bis-3,5-diisopropylsalicylate decreases tumor growth and increases survival rates in animal models of mammary cancer.